{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:36:13Z","timestamp":1792510573914,"version":"4.5.0"},"reference-count":35,"publisher":"American Medical Association (AMA)","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2024,6,18]]},"abstract":"\n Importance<\/jats:title>\n Knee osteoarthritis is disabling, with few effective treatments. Preliminary evidence suggested that krill oil supplementation improved knee pain, but effects on knee osteoarthritis remain unclear.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To evaluate efficacy of krill oil supplementation, compared with placebo, on knee pain in people with knee osteoarthritis who have significant knee pain and effusion-synovitis.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n Multicenter, randomized, double-blind, placebo-controlled clinical trial in 5 Australian cities. Participants with clinical knee osteoarthritis, significant knee pain, and effusion-synovitis on magnetic resonance imaging were enrolled from December 2016 to June 2019; final follow-up occurred on February 7, 2020.<\/jats:p>\n <\/jats:sec>\n \n Interventions<\/jats:title>\n Participants were randomized to 2 g\/d of krill oil (n\u2009=\u2009130) or matching placebo (n\u2009=\u2009132) for 24 weeks.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcome was change in knee pain as assessed by visual analog scale (range, 0-100; 0 indicating least pain; minimum clinically important improvement\u2009=\u200915) over 24 weeks.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Of 262 participants randomized (mean age, 61.6 [SD, 9.6] years; 53% women), 222 (85%) completed the trial. Krill oil did not improve knee pain compared with placebo (mean change in VAS score, \u221219.9 [krill oil] vs \u221220.2 [placebo]; between-group mean difference, \u22120.3; 95% CI, \u22126.9 to 6.4) over 24 weeks. One or more adverse events was reported by 51% in the krill oil group (67\/130) and by 54% in the placebo group (71\/132). The most common adverse events were musculoskeletal and connective tissue disorders, which occurred 32 times in the krill oil group and 42 times in the placebo group, including knee pain (n\u2009=\u200910 with krill oil; n\u2009=\u20099 with placebo), lower extremity pain (n\u2009=\u20091 with krill oil; n\u2009=\u20095 with placebo), and hip pain (n\u2009=\u20093 with krill oil; n\u2009=\u20092 with placebo).<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n Among people with knee osteoarthritis who have significant knee pain and effusion-synovitis on magnetic resonance imaging, 2 g\/d of daily krill oil supplementation did not improve knee pain over 24 weeks compared with placebo. These findings do not support krill oil for treating knee pain in this population.<\/jats:p>\n <\/jats:sec>\n \n Trial Registration<\/jats:title>\n \n Australian New Zealand Clinical Trials Registry Identifier:\n ACTRN12616000726459<\/jats:ext-link>\n ; Universal Trial Number: U1111-1181-7087\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jama.2024.6063","type":"journal-article","created":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T11:33:31Z","timestamp":1716377611000},"page":"1997","source":"Crossref","is-referenced-by-count":41,"title":["Krill Oil for Knee Osteoarthritis"],"prefix":"10.1001","volume":"331","author":[{"given":"Laura L.","family":"Laslett","sequence":"first","affiliation":[{"name":"Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieke E. J. M.","family":"Scheepers","sequence":"additional","affiliation":[{"name":"Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benny","family":"Antony","sequence":"additional","affiliation":[{"name":"Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita E.","family":"Wluka","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine, Monash University, Alfred Hospital, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqi","family":"Cai","sequence":"additional","affiliation":[{"name":"Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia"},{"name":"Department of Epidemiology and Biostatistics, Anhui Medical University, Hefei, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine L.","family":"Hill","sequence":"additional","affiliation":[{"name":"The Queen Elizabeth Hospital, University of Adelaide, Woodville, South Australia, Australia"},{"name":"Discipline of Medicine, University of Adelaide, Adelaide, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyn","family":"March","sequence":"additional","affiliation":[{"name":"The University of Sydney, Kolling Institute and Royal North Shore Hospital, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen I.","family":"Keen","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, School of Medicine and Pharmacology, Fiona Stanley Hospital, Murdoch, Western Australia, Australia"},{"name":"Medical School, University of Western Australia, Crawley, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Otahal","sequence":"additional","affiliation":[{"name":"Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia M.","family":"Cicuttini","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine, Monash University, Alfred Hospital, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Jones","sequence":"additional","affiliation":[{"name":"Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"7","key":"joi240048r1","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1136\/annrheumdis-2013-204763","article-title":"The global burden of hip and knee osteoarthritis: estimates from the Global Burden of Disease 2010 study.","volume":"73","author":"Cross","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"joi240048r2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41584-019-0221-y","article-title":"Therapeutic options for targeting inflammatory osteoarthritis pain.","volume":"15","author":"Conaghan","year":"2019","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"joi240048r3","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.bone.2012.02.012","article-title":"The role of synovitis in osteoarthritis pathogenesis.","volume":"51","author":"Scanzello","year":"2012","journal-title":"Bone"},{"issue":"3","key":"joi240048r4","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1136\/annrheumdis-2014-206676","article-title":"Association between MRI-detected knee joint regional effusion-synovitis and structural changes in older adults: a cohort study.","volume":"75","author":"Wang","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"joi240048r5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s40674-016-0041-z","article-title":"Measuring disease progression in osteoarthritis.","volume":"2","author":"Laslett","year":"2016","journal-title":"Curr Treatm Opt Rheumatol"},{"issue":"5","key":"joi240048r6","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nri2294","article-title":"Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators.","volume":"8","author":"Serhan","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"joi240048r7","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.nut.2017.06.023","article-title":"Intake of ?-3 polyunsaturated fatty acids in patients with rheumatoid arthritis: a systematic review and meta-analysis.","volume":"45","author":"Gioxari","year":"2018","journal-title":"Nutrition"},{"issue":"1","key":"joi240048r8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1136\/annrheumdis-2014-207169","article-title":"Fish oil in knee osteoarthritis: a randomised clinical trial of low dose versus high dose.","volume":"75","author":"Hill","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"joi240048r9","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.joca.2012.01.021","article-title":"Association of plasma n-6 and n-3 polyunsaturated fatty acids with synovitis in the knee: the MOST study.","volume":"20","author":"Baker","year":"2012","journal-title":"Osteoarthritis Cartilage"},{"key":"joi240048r10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/1476-511X-10-145","article-title":"Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 fatty acid formulations\u2014a comparative bioavailability study of fish oil vs. krill oil.","volume":"10","author":"Schuchardt","year":"2011","journal-title":"Lipids Health Dis"},{"issue":"2","key":"joi240048r11","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/1541-4337.12427","article-title":"Antarctic krill (Euphausia superba) oil: a comprehensive review of chemical composition, extraction technologies, health benefits, and current applications.","volume":"18","author":"Xie","year":"2019","journal-title":"Compr Rev Food Sci Food Saf"},{"key":"joi240048r12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phrs.2018.08.012","article-title":"Astaxanthin: a mechanistic review on its biological activities and health benefits.","volume":"136","author":"Fakhri","year":"2018","journal-title":"Pharmacol Res"},{"issue":"1","key":"joi240048r13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/07315724.2007.10719584","article-title":"Evaluation of the effect of Neptune krill oil on chronic inflammation and arthritic symptoms.","volume":"26","author":"Deutsch","year":"2007","journal-title":"J Am Coll Nutr"},{"issue":"10","key":"joi240048r14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0162769","article-title":"Krill oil improves mild knee joint pain: a randomized control trial.","volume":"11","author":"Suzuki","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"joi240048r15","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/ajcn\/nqac125","article-title":"Krill oil improved osteoarthritic knee pain in adults with mild to moderate knee osteoarthritis: a 6-month multicenter, randomized, double-blind, placebo-controlled trial.","volume":"116","author":"Stonehouse","year":"2022","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"joi240048r16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13063-019-3915-1","article-title":"KARAOKE: krill oil versus placebo in the treatment of knee osteoarthritis: protocol for a randomised controlled trial.","volume":"21","author":"Laslett","year":"2020","journal-title":"Trials"},{"issue":"8","key":"joi240048r17","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1002\/art.1780290816","article-title":"Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee.","volume":"29","author":"Altman","year":"1986","journal-title":"Arthritis Rheum"},{"issue":"1","key":"joi240048r18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3899\/jrheum.150355","article-title":"Cross-sectional and longitudinal associations between knee joint effusion synovitis and knee pain in older adults.","volume":"43","author":"Wang","year":"2016","journal-title":"J Rheumatol"},{"key":"joi240048r19","first-page":"3","article-title":"Atlas of individual radiographic features in osteoarthritis.","volume":"3","author":"Altman","year":"1995","journal-title":"Osteoarthritis Cartilage"},{"issue":"5","key":"joi240048r20","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/cpt1974155443","article-title":"Minimization: a new method of assigning patients to treatment and control groups.","volume":"15","author":"Taves","year":"1974","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"joi240048r21","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1002\/acr.21747","article-title":"Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: results from a prospective multinational study.","volume":"64","author":"Tubach","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"12","key":"joi240048r22","first-page":"1833","article-title":"Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee.","volume":"15","author":"Bellamy","year":"1988","journal-title":"J Rheumatol"},{"issue":"4","key":"joi240048r23","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/1529-0131(200108)45:4<384::AID-ART352>3.0.CO;2-0","article-title":"Smallest detectable and minimal clinically important differences of rehabilitation intervention with their implications for required sample sizes using WOMAC and SF-36 quality of life measurement instruments in patients with osteoarthritis of the lower extremities.","volume":"45","author":"Angst","year":"2001","journal-title":"Arthritis Rheum"},{"key":"joi240048r24","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1471-2474-11-80","article-title":"The visual analogue WOMAC 3.0 scale\u2014internal validity and responsiveness of the VAS version.","volume":"11","author":"Kersten","year":"2010","journal-title":"BMC Musculoskelet Disord"},{"issue":"5","key":"joi240048r25","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.joca.2004.02.001","article-title":"OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited.","volume":"12","author":"Pham","year":"2004","journal-title":"Osteoarthritis Cartilage"},{"key":"joi240048r26","doi-asserted-by":"crossref","first-page":"m4743","DOI":"10.1136\/bmj.m4743","article-title":"Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: systematic review and meta-analysis of published and unpublished randomized trial data.","volume":"372","author":"Goldenberg","year":"2021","journal-title":"BMJ"},{"issue":"4","key":"joi240048r28","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.joca.2007.12.015","article-title":"Development and preliminary psychometric testing of a new OA pain measure\u2014an OARSI\/OMERACT initiative.","volume":"16","author":"Hawker","year":"2008","journal-title":"Osteoarthritis Cartilage"},{"issue":"3","key":"joi240048r29","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3899\/jrheum.130609","article-title":"Reliability and clinically important improvement thresholds for osteoarthritis pain and function scales: a multicenter study.","volume":"41","author":"Singh","year":"2014","journal-title":"J Rheumatol"},{"issue":"4","key":"joi240048r30","doi-asserted-by":"crossref","first-page":"137","DOI":"10.21767\/2386-5180.1000137","article-title":"Measurement of the omega-3 index in dried blood spots.","volume":"4","author":"Harris","year":"2016","journal-title":"Ann Clin Lab Res"},{"issue":"4","key":"joi240048r31","first-page":"685","article-title":"How should we measure medication adherence in clinical trials and practice?","volume":"3","author":"Lee","year":"2007","journal-title":"Ther Clin Risk Manag"},{"issue":"11","key":"joi240048r32","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.joca.2012.07.019","article-title":"Treatment with 4Jointz reduces knee pain over 12 weeks of treatment in patients with clinical knee osteoarthritis: a randomised controlled trial.","volume":"20","author":"Laslett","year":"2012","journal-title":"Osteoarthritis Cartilage"},{"issue":"10","key":"joi240048r33","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1001\/jama.2016.1961","article-title":"Effect of vitamin D supplementation on tibial cartilage volume and knee pain among patients with symptomatic knee osteoarthritis: a randomized clinical trial.","volume":"315","author":"Jin","year":"2016","journal-title":"JAMA"},{"issue":"1","key":"joi240048r34","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1477-7525-10-38","article-title":"Construction of the descriptive system for the Assessment of Quality of Life AQoL-6D utility instrument.","volume":"10","author":"Richardson","year":"2012","journal-title":"Health Qual Life Outcomes"},{"issue":"15","key":"joi240048r35","doi-asserted-by":"crossref","first-page":"e867","DOI":"10.1161\/CIR.0000000000000482","article-title":"Omega-3 polyunsaturated fatty acid (fish oil) supplementation and the prevention of clinical cardiovascular disease: a science advisory from the American Heart Association.","volume":"135","author":"Siscovick","year":"2017","journal-title":"Circulation"},{"key":"joi240048r27","unstructured":"Assessment of Quality of Life. AQoL-6D. Accessed November 21, 2023. http:\/\/www.aqol.com.au\/aqolquestionnaires\/56.html"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2819125\/jama_laslett_2024_oi_240048_1727199125.7595.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T11:53:27Z","timestamp":1727351607000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2819125"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2024,6,18]]},"references-count":35,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2024,6,18]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2024.6063","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,18]]}}}